BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Exploit Technologies To Divest Part Of Its Shares In BuzzCity To Myriad International Holdings Bv For US $1 Million


8/13/2009 12:32:58 PM

Exploit Technologies, the marketing and commercialisation arm of A*STAR, today announced it has entered into an agreement to divest part of its shares in Buzzcity Pty Ltd (“BuzzCity”) to Myriad International Holdings BV (“MIH”) for US$1 million.

With the divestment, Exploit Technologies continues to own just above 5% of the shares in BuzzCity. The Singapore based mobile advertising company has been Exploit Technologies’ portfolio company since 1999, after it spun off from the Singapore Agency for Science, technology and Research (A*STAR). Exploit Technologies will carry on its active advisory role to BuzzCity’s management team after the completion of the transaction.

The current transaction marks MIH’s second round of acquisition of BuzzCity shares. MIH, a subsidiary of the South African media conglomerate, Naspers, had in August 2008 invested US$10 million to acquire a 25% stake in BuzzCity, a developer of wireless communities and consumer services.

Commenting on the divestment, Mr Boon Swan Foo, Executive Chairman of Exploit Technologies, said, “Given Naspers’ experience and foothold in the media industry, MIH’s acquisition of a higher stake in BuzzCity, despite the uncertain economic outlook, is a strong testimony of BuzzCity’s business model and the attraction of its expansive new media markets. This made-in-Singapore company is definitely speaking a language that media companies understand. With a structured business incubation process in place to nurture a pipeline of high potential start-ups, Exploit Technologies is confident that more of our portfolio companies will catch the eyes of talent scouts, like MIH, to forge strategic partnerships and break into new markets.”

About Exploit Technologies Pte Ltd

Exploit Technologies is the strategic marketing and commercialisation arm of the Agency for Science, Technology and Research (A*STAR). Its mission is to support A*STAR in transforming the economy through commercialising R&D. Exploit Technologies enhances the research output of A*STAR scientists by translating their inventions into marketable products or processes. Through licensing deals and spinoffs with industry partners, Exploit Technologies is a key driver of technology transfer in Singapore. It actively engages industry leaders and players to commercialise A*STAR's technologies and capabilities, bridging the gap from Mind to Market. Exploit Technologies’ charter is to identify, protect and exploit promising intellectual property (IP) created by A*STAR’s research institutes.

For more information, please visit http://www.exploit-tech.com


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES